Page last updated: 2024-09-03

indanidine and neuropeptide y (13-36)

indanidine has been researched along with neuropeptide y (13-36) in 1 studies

Compound Research Comparison

Studies (indanidine)	Trials (indanidine)	Recent Studies (post-2010) (indanidine)	Studies (neuropeptide y (13-36))	Trials (neuropeptide y (13-36))	Recent Studies (post-2010) (neuropeptide y (13-36))
26	0	1	76	0	6

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, X; Doughty, MB; Miller, DW; Misse, GA; Tessel, RE	1

Other Studies

1 other study(ies) available for indanidine and neuropeptide y (13-36)

Article	Year
Characterization of vascular postsynaptic NPY receptor function and regulation and differential sensitivity of Y1 and Y2 receptor function to changes in extracellular calcium availability and prior in vitro peptide exposure. Neuropeptides, 1993, Volume: 25, Issue:5 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Calcium; Clonidine; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synapses; Vasoconstrictor Agents	1993

Article

Year

Characterization of vascular postsynaptic NPY receptor function and regulation and differential sensitivity of Y1 and Y2 receptor function to changes in extracellular calcium availability and prior in vitro peptide exposure.

Neuropeptides, 1993, Volume: 25, Issue:5

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Calcium; Clonidine; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synapses; Vasoconstrictor Agents

1993